 |
Chelmicka-Schorr, Ewa, MD
Professor (Neurology and Pediatrics)
Co-Director, Muscular Dystrophy Association Clinic
| Address: |
5841 S. Maryland Ave., MC 2030
Chicago, IL 60637-1470 |
| Telephone: |
773-702-6394 |
| Secretary: |
TBN |
| Patient Calls: |
773-702-6394 |
| Fax: |
773-702-9060 |
|
|
Education & Training
- M.D., Warsaw, Poland
- Residency (Pediatrics and Neurology), Medical School Hospital, Warsaw, Poland
- Fellowship, Massachusetts General Hospital, Boston, MA
- Board Certified in Neurology with special competence in Child Neurology, American Board of Psychiatry and Neurology
Clinical Interests
- Epilepsy (Pediatric Neurology)
- Neuromuscular diseases (Pediatric Neurology)
- Neuroimmune diseases (Pediatric Neurology)
- Complicated seizure disorders (Pediatric Neurology)
- Cerebral palsy (Pediatric Neurology)
- Pediatric multiple sclerosis
- Inflammatory demyelinating polyradiculoneuropathy (Pediatric Neurology)
- Myasthenia gravis (Pediatric Neurology)
Research Interests
- Dr. Schorr’s major research interest is in the effect of the sympathetic nervous system on immune responses and on experimental autoimmune diseases: experimental allergic encephalomyelitis (EAE), experimental allergic neuritis (EAN), and experimental allergic myasthenia gravis (EAMG). Dr. Schorr is studying the effect of treatment with beta-adrenergic agonists on EAE, EAN and EAMG. Her clinical research involves the treatment of multiple sclerosis and myasthenia gravis with the beta-adrenergic agonist Terbutaline. Dr. Schorr has also studied the immunoaugementing and immunosupressing effects of the immunosuppressive drugs in experimental allergic encephalomyelitis.
Teaching
- Monthly Pediatric Neurology Conference (Department of Neurology, The University of Chicago Medical Center)
Selected Publications
- McLeod H., Pytel P., Wollmann R., Chelmicka-Schorr, E., Silver, K., Brown Anderson R., Waggoner D., and McNally E. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycolprotein complex, 2006 Neuromuscular Disorders, Submitted.
- Chelmicka-Schorr, E., Arnason, B.G., Interactions between the sympathetic nervous system and the immune system. Brain Behav Immun. 1999 Dec: 13(4): 271-8.
- Chelmicka-Schorr, E., Wiegmann, K., Wollman, R., Arnason, B.G., Kim, D.H. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. J. Autoimmun. 1998 Aug: 11(4): 329-34.
- Muthyala, S., Weigmann, K., Kim, D.H., Arnason B.G., Chelmicka-Schorr, E., Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta adrenergic agonist-treated rats. Int J Immunopharmacol. 1995 Nov; 17(11)895 -901.
- Weignamm, K., Muthyala S., Kim, D.H., Arnason, B.G., Chelmicka-Schorr, E., Beta-adrenerigic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol. 1995 Feb: 56 (2): 201-6.
- Chelmicka-Schorr, E., Arnason, B.G., Nervous system-immune system interactions and their role in multiple sclerosis. Ann Neurol. 1994:36 Suppl:S29-32.
Back to Top |
|
|